
National Association of Testing Authorities, Australia
Scope of Accreditation
Genomics for Life Pty Ltd
Site
Xytogen
Accreditation No.
19325
Site No.
25259
Date of Accreditation
11 May 2022
Contact
Ms Sandra Stein
P: +61 0418711096
Availability
Services available to external clients
Supervision
B (Branch)
Scope of Accreditation
Withdrawn 14 Jun 2023
Voluntary
Xytogen
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Mobile Testing
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Safe2Travel
ISO 15189 (2012)
Human Pathology
|
||
Service | Product | Determinant |
---|---|---|
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
19325
Site No.
25259
Print date
08 Dec 2023
END OF SCOPE